EVOGENE LTD. (EVGN) Stock Price

EVGNStock

$0.55−57.49%52W

Market Cap$8.68M

P/E—

PEG Ratio—

Div yield—

Beta1.40

EVGN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-46.37%

Price vs S&P 500 (4W)1.00%

VGM Score49.08

Book Value / Share (Quarterly)$0.13

P/TBV (Annual)2.18x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)30.54%

Cash Flow / Share (Quarterly)$-1.08

Price vs S&P 500 (YTD)-62.86%

Gross Margin (TTM)71.02%

Net Profit Margin (TTM)-392.14%

EPS (TTM)$-1.38

10-Day Avg Trading Volume0.24M

EPS Excl Extra (TTM)$-1.38

Revenue Growth (5Y)-13.11%

EPS (Annual)$-1.08

ROI (Annual)-101.36%

Gross Margin (Annual)-120.56%

Net Profit Margin (5Y Avg)-2057.32%

Cash / Share (Quarterly)$1.25

Revenue Growth QoQ (YoY)708.37%

ROA (Last FY)-42.33%

Revenue Growth TTM (YoY)331.52%

EBITD / Share (TTM)$-1.38

ROE (5Y Avg)-46.94%

Operating Margin (TTM)-457.22%

Cash Flow / Share (Annual)$-1.56

P/B Ratio9.25x

P/B Ratio (Quarterly)8.71x

Net Income / Employee (Annual)$-59,800

EV / Revenue (TTM)2.79x

Net Interest Coverage (TTM)-101.26x

ROA (TTM)-48.03%

EV / EBITDA (TTM)-6.35x

EPS Incl Extra (Annual)$-1.08

Current Ratio (Annual)4.54x

Quick Ratio (Quarterly)2.76x

3-Month Avg Trading Volume1.34M

52-Week Price Return-57.49%

Revenue / Employee (TTM)$41,766,420,000

Tangible BV / Share (Quarterly)$0.13

P/S Ratio (Annual)3.54x

Asset Turnover (Annual)0.06x

52-Week High$1.50

Operating Margin (5Y Avg)-2072.63%

EPS Excl Extra (Annual)$-1.08

CapEx CAGR (5Y)14.69%

Tangible BV CAGR (5Y)-27.61%

26-Week Price Return-34.44%

Quick Ratio (Annual)4.33x

13-Week Price Return-23.14%

Total Debt / Equity (Annual)0.95x

Current Ratio (Quarterly)2.79x

Enterprise Value$4.09M

Revenue / Share Growth (5Y)-20.95%

Asset Turnover (TTM)0.10x

Book Value / Share Growth (5Y)-24.14%

Revenue / Employee (Annual)$21,000

Inventory Turnover (Annual)19.52x

Pretax Margin (Annual)-735.95%

Cash / Share (Annual)$1.49

3-Month Return Std Dev114.23%

Gross Margin (5Y Avg)-168.64%

Net Income / Employee (TTM)$-82,900

ROE (Last FY)-198.12%

Net Interest Coverage (Annual)-3.89x

EPS Basic Excl Extra (Annual)$-1.08

P/FCF (TTM)7.12x

Receivables Turnover (TTM)6.37x

Total Debt / Equity (Quarterly)2.21x

EPS Incl Extra (TTM)$-1.38

Receivables Turnover (Annual)5.33x

ROI (TTM)-56.10%

P/S Ratio (TTM)5.26x

Pretax Margin (5Y Avg)-2054.24%

Revenue / Share (Annual)$0.65

Tangible BV / Share (Annual)$0.33

Price vs S&P 500 (52W)-76.05%

EPS Growth TTM (YoY)37.04%

Year-to-Date Return-50.04%

5-Day Price Return-1.68%

EPS Normalized (Annual)$-1.08

ROA (5Y Avg)-36.63%

Net Profit Margin (Annual)-800.77%

Month-to-Date Return16.69%

Cash Flow / Share (TTM)$-0.46

EBITD / Share (Annual)$-1.64

Operating Margin (Annual)-745.51%

LT Debt / Equity (Annual)0.86x

ROI (5Y Avg)-45.49%

LT Debt / Equity (Quarterly)57.69x

EPS Basic Excl Extra (TTM)$-1.38

P/TBV (Quarterly)8.71x

P/B Ratio (Annual)3.52x

Inventory Turnover (TTM)0.37x

Pretax Margin (TTM)-391.86%

Book Value / Share (Annual)$2.38

Price vs S&P 500 (13W)-25.10%

Beta1.40x

P/FCF (Annual)0.69x

Revenue / Share (TTM)$0.13

ROE (TTM)-38.31%

52-Week Low$0.37

vGradeC

gGradeB

mGradeD

vgmGradeC

EVGN Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 18, 2026	-$0.27	-$0.13	+51.67%(+$0.14)
Q1 2026	May 20, 2026	-$0.27	-$0.61	-125.74%(-$0.34)
Q4 2025	Mar 5, 2026	-$0.26	-$0.62	-137.46%(-$0.36)
Q3 2025	Nov 20, 2025	-$0.41	-$0.46	-13.39%(-$0.05)
Q2 2025	Aug 19, 2025	-$0.63	-$0.50	+20.63%(+$0.13)

EVGN Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.14

Industry Peers — Agricultural Chemicals(11)

Symbol	Value Score	Growth Score	Momentum Score	Price
EVGNEVOGENE LTD.	C	B	D	$0.55
NTRNutrien Ltd. Common Shares	B	B	B	$73.51
CFCF Industries Holding, Inc.	B	B	B	$125.79
MOSThe Mosaic Company	B	C	C	$23.60
ICLICL Group Ltd.	B	C	D	$5.60
SMGThe Scotts Miracle-Gro Company	B	D	C	$60.43
UANCVR Partners, LP	B	B	B	$125.28
CBUSCibus, Inc. Class A Common Stock	D	D	C	$1.65
AVDAmerican Vanguard Corporation	B	C	D	$2.19
BIOXBioceres Crop Solutions Corp. Ordinary Shares	B	C	D	$0.41
FRTTFort Technology Inc. Common Shares	—	—	D	$0.94
SNESSenesTech, Inc. Common Stock	A	B	F	$1.08

About EVOGENE LTD.

Evogene Ltd is a computational biology company that uses its Computational Predictive Biology platform to discover and develop life-science products based on microbes, small molecules, and genetic elements. The company operates across three sectors—agriculture, human health, and industrial applications—through a portfolio of subsidiaries developing agricultural biologicals, seed traits, microbiome therapeutics, and specialty chemicals. Revenue is generated primarily from the agriculture segment.